Does REMIMAZOLAM Cause Electrocardiogram qt prolonged? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Electrocardiogram qt prolonged have been filed in association with REMIMAZOLAM (BYFAVO). This represents 3.7% of all adverse event reports for REMIMAZOLAM.
5
Reports of Electrocardiogram qt prolonged with REMIMAZOLAM
3.7%
of all REMIMAZOLAM reports
0
Deaths
3
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From REMIMAZOLAM?
Of the 5 reports, 3 (60.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMIMAZOLAM. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does REMIMAZOLAM Cause?
Anaphylactic shock (21)
Anaphylactic reaction (11)
Vascular access site occlusion (11)
Cardiac arrest (10)
Hypotension (10)
Oxygen saturation decreased (9)
Blood pressure decreased (8)
Off label use (8)
Bronchospasm (6)
Circulatory collapse (6)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which REMIMAZOLAM Alternatives Have Lower Electrocardiogram qt prolonged Risk?
REMIMAZOLAM vs REMODULIN
REMIMAZOLAM vs REPAGLINIDE
REMIMAZOLAM vs REPOTRECTINIB
REMIMAZOLAM vs REQUIP
REMIMAZOLAM vs RESLIZUMAB